Search Results - "Current oncology (Toronto)"
-
1
Immune Checkpoint Inhibitors in Cancer Therapy
Published in Current oncology (Toronto) (24-04-2022)“…The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents a significant breakthrough in the field of cancer immunotherapy…”
Get full text
Journal Article -
2
A review of cancer immunotherapy: from the past, to the present, to the future
Published in Current oncology (Toronto) (01-04-2020)“…Compared with previous standards of care (including chemotherapy, radiotherapy, and surgery), cancer immunotherapy has brought significant improvements for…”
Get full text
Journal Article -
3
Exercise for people with cancer: a clinical practice guideline
Published in Current oncology (Toronto) (01-02-2017)“…Development of this guideline was undertaken by the Exercise for People with Cancer Guideline Development Group, a group organized by Cancer Care Ontario's…”
Get full text
Journal Article -
4
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
Published in Current oncology (Toronto) (09-03-2022)“…Lung cancer is the leading cause of cancer death in Canada and a significant cause of morbidity for patients and their loved ones. There have been rapid…”
Get full text
Journal Article -
5
Anticancer mechanisms of cannabinoids
Published in Current oncology (Toronto) (01-03-2016)“…In addition to the well-known palliative effects of cannabinoids on some cancer-associated symptoms, a large body of evidence shows that these molecules can…”
Get full text
Journal Article -
6
Exercise for people with cancer: a systematic review
Published in Current oncology (Toronto) (31-08-2017)“…This systematic review was completed by the Exercise for People with Cancer Guideline Development Group, a group organized by Cancer Care Ontario's Program in…”
Get full text
Journal Article -
7
Advances in the systemic treatment of triple-negative breast cancer
Published in Current oncology (Toronto) (01-06-2018)“…Triple-negative breast cancer constitutes a heterogeneous group of malignancies that are often aggressive and associated with a poor prognosis. Molecular…”
Get full text
Journal Article -
8
Immunotherapy in Gastric Cancer
Published in Current oncology (Toronto) (02-03-2022)“…Immune checkpoint inhibition is a new standard of targeted therapy in the treatment of advanced or metastatic gastric cancer (GC) and is represented in various…”
Get full text
Journal Article -
9
Synovial Sarcoma: A Clinical Review
Published in Current oncology (Toronto) (19-05-2021)“…Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and account for 5–10% of all STS. Synovial sarcoma differs from other STS by the…”
Get full text
Journal Article -
10
A general practitioner's guide to hematopoietic stem-cell transplantation
Published in Current oncology (Toronto) (01-06-2019)“…Hematopoietic stem-cell transplantation (hsct) is a medical procedure that consists of infusing stem cells after a short course of chemotherapy or…”
Get full text
Journal Article -
11
Exercise for People with Cancer: A Systematic Review
Published in Current oncology (Toronto) (01-08-2017)“…Background: This systematic review was completed by the Exercise for People with Cancer Guideline Development Group, a group organized by Cancer Care Ontario’s…”
Get full text
Journal Article -
12
Pathological Features and Prognostication in Colorectal Cancer
Published in Current oncology (Toronto) (13-12-2021)“…The prognostication of colorectal cancer (CRC) has traditionally relied on staging as defined by the Union for International Cancer Control (UICC) and American…”
Get full text
Journal Article -
13
Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era
Published in Current oncology (Toronto) (23-04-2021)“…The development of artificial intelligence (AI) algorithms has permeated the medical field with great success. The widespread use of AI technology in…”
Get full text
Journal Article -
14
Rates of cannabis use in patients with cancer
Published in Current oncology (Toronto) (01-06-2018)“…A comprehensive assessment of cannabis use by patients with cancer has not previously been reported. In this study, we aimed to characterize patient…”
Get full text
Journal Article -
15
Screening for breast cancer in 2018-what should we be doing today?
Published in Current oncology (Toronto) (01-06-2018)“…Although screening mammography has delivered many benefits since its introduction in Canada in 1988, questions about perceived harms warrant an up-to-date…”
Get full text
Journal Article -
16
Classification of Brain Tumor from Magnetic Resonance Imaging Using Vision Transformers Ensembling
Published in Current oncology (Toronto) (01-10-2022)“…The automated classification of brain tumors plays an important role in supporting radiologists in decision making. Recently, vision transformer (ViT)-based…”
Get full text
Journal Article -
17
The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review
Published in Current oncology (Toronto) (15-03-2021)“…Out-of-pocket costs pose a substantial economic burden to cancer patients and their families. The purpose of this study was to evaluate the literature on…”
Get full text
Journal Article -
18
The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review
Published in Current oncology (Toronto) (20-10-2021)“…The large burden of COVID-19 on health care systems worldwide has raised concerns among medical oncologists about the impact of COVID-19 on the diagnosis and…”
Get full text
Journal Article -
19
Current Overview of Treatment for Metastatic Bone Disease
Published in Current oncology (Toronto) (29-08-2021)“…The number of patients with bone metastasis increases as medical management and surgery improve the overall survival of patients with cancer. Bone metastasis…”
Get full text
Journal Article -
20
Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer
Published in Current oncology (Toronto) (22-02-2019)“…For more than a decade, there has been no improvement in outcomes for patients with unresectable locally advanced (la) non-small-cell lung cancer (nsclc). The…”
Get full text
Journal Article